Form D/A - Notice of Exempt Offering of Securities: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form D/A - Notice of Exempt Offering of Securities: [Amend]

HeartSciences (NASDAQ:HSCS)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more HeartSciences Charts.

HeartSciences (NASDAQ:HSCS)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more HeartSciences Charts.

Heart Test Laboratories Inc News

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
Monday 16 December 2024 (4 days ago) • GlobeNewswire Inc.

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
Wednesday 13 November 2024 (1 month ago) • GlobeNewswire Inc.

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Monday 14 October 2024 (2 months ago) • GlobeNewswire Inc.

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
Thursday 12 September 2024 (3 months ago) • GlobeNewswire Inc.

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
Thursday 12 September 2024 (3 months ago) • GlobeNewswire Inc.

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
Monday 29 July 2024 (5 months ago) • GlobeNewswire Inc.

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
Friday 26 July 2024 (5 months ago) • GlobeNewswire Inc.

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
Thursday 25 July 2024 (5 months ago) • GlobeNewswire Inc.

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
Thursday 11 July 2024 (5 months ago) • GlobeNewswire Inc.

HeartSciences Regains Compliance with Nasdaq Listing Requirements
Tuesday 4 June 2024 (7 months ago) • GlobeNewswire Inc.

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
Monday 20 May 2024 (7 months ago) • GlobeNewswire Inc.

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
Wednesday 24 April 2024 (8 months ago) • GlobeNewswire Inc.

More Heart Test Laboratories Inc News Articles

Impact Fusion (PK)

CyberFuels (PK)

GBT Technologies (PK)

KULR Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions